Live Breaking News & Updates on Squamous Carcinoma|Page 10
Stay updated with breaking news from Squamous carcinoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A combination of immune stimulants and immunotherapy that transforms tumors into cancer vaccine-producing factories has shown remarkable promise in a phase 1/2 trial, although only in 30% of patients. ....
Adults with dermatologic conditions such as hidradenitis suppurativa "may be at increased risk for persistent and high-risk HPV infection" and may benefit from HPV vaccination, study authors said. ....
The new approval expands use of the PD-1 inhibitor cemiplimab (Libtayo) to patients with advanced non–small cell lung cancer (NSCLC) irrespective of PD-LI expression. ....
Once again, the US Preventive Services Task Force has concluded that there is insufficient evidence on the balance of benefits vs the harms of screening asymptomatic patients for skin cancer. ....